After UK, Canada approves Pfizer/BioNTech Covid-19 vaccine
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Get authentic, real-time news that helps you fight COVID-19 better.
Install PlexusMD App for doctors. It's free.
Pfizer Canada and BioNTech SE announced that Health Canada has granted Authorization under Interim Order for the emergency use of their mRNA COVID-19 vaccine (BNT162b2).

With this, Canada becomes the second Western country after Britain to approve administration of the Covid-19 vaccine for its citizens.

The initial indication of the vaccine is for use in people 16 years of age or older. Pfizer-BioNTech is running further clinical trials on children of all age groups and the indication could be revised in the future to include children if the data from these studies support it, stated in Health Canada’s announcement.

BioNTech will hold the regulatory approval in Canada, while Pfizer Canada will have the commercialization rights.

Health Canada’s decision is based on data that was filed through the rolling submission regulatory pathway, and includes data from the Phase 2/3 clinical trial, which began recruiting in late-July 2020, and enrolled approximately 44,000 people across approximately 150 sites in multiple countries.

Pfizer Canada and BioNTech will supply the Government of Canada a minimum of 20 million doses (and up to 76 million doses) of the vaccine through 2021.

Source:
1. https://www.globenewswire.com/news-release/2020/12/09/2142483/0/en/Pfizer-and-BioNTech-Achieve-Health-Canada-Authorization-for-Their-Vaccine-to-Combat-COVID-19.html
2. https://in.reuters.com/article/health-coronavirus-canada-vaccine/health-canadas-statement-approving-pfizer-biontech-covid-19-vaccine-idINKBN28J2DJ
Dr. T●●●●z H●●●●●●i and 2 other likes this1 share
Like
Comment
Share